ConsentFix and ClickFix attacks steal Microsoft 365 tokens in seconds using fake prompts and OAuth flows. Learn how these MFA ...

Back in June 2024, Apple Intelligence was unveiled with very limited hardware support in iOS 18. Apple said it would be available on iPhone 15 Pro or iPhone 15 Pro Max—that’s it. At the time, that ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. A ...

Ajax Therapeutics is among about 10 publicly-announced acquisitions by Eli Lilly so far this year. (Angus Liu/Fierce Pharma) Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Database startup Supabase announced a $500 million funding round that values the company at $10.5 billion, including the fresh capital. Supabase provides back-end technology for vibe coders. "I built ...

Arne Slot has turned down the chance to take charge of Ajax and wants to continue as the manager of Liverpool, according to a reliable Dutch journalist. Slot was appointed the Liverpool manager in the ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Eli Lilly LLY-1.21%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...